相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。How I treat acute myeloid leukemia presenting with preexisting comorbidities
Yishai Ofran et al.
BLOOD (2016)
Glutathione biosynthesis is a metabolic vulnerability in PI(3)K/Akt-driven breast cancer
Evan C. Lien et al.
NATURE CELL BIOLOGY (2016)
Suppression of NRF2-ARE activity sensitizes chemotherapeutic agent-induced cytotoxicity in human acute monocytic leukemia cells
Hui Peng et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2016)
Cellular localization of NRF2 determines the self-renewal and osteogenic differentiation potential of human MSCs via the P53-SIRT1 axis
D. S. Yoon et al.
CELL DEATH & DISEASE (2016)
Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2
Adedamola Olayanju et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Replication stress activates DNA repair synthesis in mitosis
Sheroy Minocherhomji et al.
NATURE (2015)
Oncogenic KRAS Confers Chemoresistance by Upregulating NRF2
Shasha Tao et al.
CANCER RESEARCH (2014)
Nuclear Heme Oxygenase-1 (HO-1) Modulates Subcellular Distribution and Activation of Nrf2, Impacting Metabolic and Anti-oxidant Defenses
Chhanda Biswas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Epigenetic modification of Nrf2 in 5-fluorouracil-resistant colon cancer cells: involvement of TET-dependent DNA demethylation
K. A. Kang et al.
CELL DEATH & DISEASE (2014)
Nrf2 Overexpression Predicts Prognosis and 5-FU Resistance in Gastric Cancer
Xiu-Feng Hu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Overproduction of NOX-derived ROS in AML promotes proliferation and is associated with defective oxidative stress signaling
Paul S. Hole et al.
BLOOD (2013)
Apigenin sensitizes doxorubicin-resistant hepatocellular carcinoma BEL-7402/ADM cells to doxorubicin via inhibiting PI3K/Akt/Nrf2 pathway
Ai-Mei Gao et al.
CARCINOGENESIS (2013)
BCL-2 Inhibition Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells
Eleni D. Lagadinou et al.
CELL STEM CELL (2013)
Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity
A. Arlt et al.
ONCOGENE (2013)
The FLT3 Inhibitor Quizartinib Inhibits ABCG2 at Pharmacologically Relevant Concentrations, with Implications for Both Chemosensitization and Adverse Drug Interactions
Jasjeet Bhullar et al.
PLOS ONE (2013)
Low-dose triptolide in combination with idarubicin induces apoptosis in AML leukemic stem-like KG1a cell line by modulation of the intrinsic and extrinsic factors
Y. Liu et al.
CELL DEATH & DISEASE (2013)
The high Nrf2 expression in human acute myeloid leukemia is driven by NF-κB and underlies its chemo-resistance
Stuart A. Rushworth et al.
BLOOD (2012)
Methylation of the KEAP1 gene promoter region in human colorectal cancer
Naoyuki Hanada et al.
BMC CANCER (2012)
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
Yoichiro Mitsuishi et al.
CANCER CELL (2012)
Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs
Xiuwen Tang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Prediction of Early Death After Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia With Pretreatment Risk Scores: A Novel Paradigm for Treatment Assignment
Roland B. Walter et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy
Adam Lister et al.
MOLECULAR CANCER (2011)
Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism
Dongmei Ren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The Role of Nrf2 and Cytoprotection in Regulating Chemotherapy Resistance of Human Leukemia Cells
Stuart A. Rushworth et al.
Cancers (2011)
Expected long-term survival of patients diagnosed with acute myeloblastic leukemia during 2006-2010
D. Pulte et al.
ANNALS OF ONCOLOGY (2010)
The NRF2-mediated oxidative stress response pathway is associated with tumor cell resistance to arsenic trioxide across the NCI-60 panel
Qian Liu et al.
BMC MEDICAL GENOMICS (2010)
Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth
Tsutonm Ohta et al.
CANCER RESEARCH (2008)
Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
Xiao-Jun Wang et al.
CARCINOGENESIS (2008)
Peroxynitrite induces HO-1 expression via PI3K/Akt-dependent activation of NF-E2-related factor 2 in PC12 cells
Mei-Hua Li et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
分享论文
